European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live11-11

European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.59% to 1,890.80 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and accommodations booking company trivago (TRVG), which increased 0.8% and 0.3% respectively. They were followed by lender Banco Santander (SAN) and medical device maker EDAP TMS (FOCL), which advanced 0.9% and 1.1% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and oil and gas company Eni (E), which dropped 2% and 2.3% respectively. They were followed by petroleum refiner Equinor (EQNR) and healthcare tech company Philips (PHG), which lost 2% and 1.5% respectively.

The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and tobacco company British American Tobacco (BTI), which rose 7.7% and 0.8% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which were up 2.6% and 0.1%, respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and oil and gas company Shell (SHEL), which fell 5.1% and 2%, respectively. They were followed by pharmaceutical company medica device maker Smith & Nephew (SNN), which was down 1.3%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment